Prognostic analysis of cT1-3N1M0 breast cancer patients who have responded to neoadjuvant therapy undergoing various axillary surgery and breast surgery based on propensity score matching and competitive risk model.

Front Oncol · 2024 · PMC10847357 · PMID 38327751

Europe PMC DOI

hedged sentence

0.3220

closest p · 6.4× alpha

0.3220

boldest claim

The sentences

did not reach statistical significanceP=0.322not close (p > 0.1)

However, these differences did not reach statistical significance (HR=1.10, 95% CI 0.91-1.31, P=0.322 vs.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.